Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing
Nissenson, A.R.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 12(4): 350-352
1992
ISSN/ISBN: 0896-8608 PMID: 1420491 Document Number: 400243
Document emailed within 1 workday
Related Documents
Boelaert, J.R.; Schurgers, M.L.; Matthys, E.G.; Belpaire, F.M.; Daneels, R.F.; De Cre, M.J.; Bogaert, M.G. 1989: Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(2): 95-98Lai, P.C.; Wu, M.S.; Huang, J.Y.; Huang, C.C.; Leu, M.L. 1994: Efficacy of intravenous and subcutaneous erythropoietin in patients on hemodialysis and continuous ambulatory peritoneal dialysis Changgeng Yi Xue Za Zhi 17(2): 105-112
Moberly, J.B.; Sorkin, M.; Kucharski, A.; Ogle, K.; Mongoven, J.; Skoufos, L.; Lin, L.; Bailey, S.; Rodela, H.; Mupas, L.; Walele, A.; Ogrinc, F.; White, D.; Wolfson, M.; Martis, L.; Breborowicz, A.; Oreopoulos, D.G. 2003: Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(1): 63-73
Riambau, E.; Aubia, J.; Llorach, I.; Lloveras, J.; Masramón, J.; Orfila, A.; Llorach, M. 1982: Intraperitoneal insulin in continuous ambulatory peritoneal dialysis Revista Clinica Espanola 164(5): 333-334
Morris, A.T.; Ronco, C. 2000: Erythropoietin therapy in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 2): S178-S182
Bargman, J. 1989: Recombinant human erythropoietin in patients on peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(4): 245-246
Balfe, J.W. 1996: Intraperitoneal amino acids in children receiving chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 16(Suppl 1): S515-S516
Montenegro, J. 2008: Phosphorus (P) chelant in dialysis: efficacy and cost. Peritoneal dialysis solutions Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(Suppl 5): 53-57
Shemin, D.; Maaz, D. 1996: Gram-negative peritonitis in peritoneal dialysis: improved outcome with intraperitoneal ceftazidime Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 16(6): 638-641
Manley, H.J.; Bailie, G.R.; Asher, R.D.; Eisele, G.; Frye, R.F. 1999: Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(1): 65-70
Makruasi, N.; Changsirikulchai, S.; Janma, J.; Rattanamongkolgul, S. 2016: Factors Related to Erythropoietin Hyporesponsiveness in Peritoneal Dialysis Patients with Anemia Journal of the Medical Association of Thailand 99(Suppl 8): S48-S52
Krack, G.; Viglino, G.; Cavalli, P.L.; Gandolfo, C.; Magliano, G.; Cantaluppi, A.; Peluso, F. 1992: Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 12(4): 359-364
Maksic, D.; Vasilijic, S.; Colic, M.; Stankovic-Popovic, V.; Bokonjic, D. 2009: Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 25: 50-55
Tsai, J.C.; Lai, Y.H.; Tsai, Z.Y.; Chien, L.J.; Tsai, J.H. 1991: Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135
Torun, D.; Oguzkurt, L.; Sezer, S.; Zumrutdal, A.; Singan, M.; Adam, F.U.; Ozdemir, F.N.; Haberal, M. 2005: Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(6): 596-600
Sifil, A.; Mermut, C.; Yenicerioglu, Y.; Cavdar, C.; Gumustekin, M.; Celik, A.; Yuksel, F.; Camsari, T. 2003: Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 28-30
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Zelichowski, G.; Lubas, A.; Sienkiewicz, M.; Janusz, E.; Wańkowicz, Z. 2008: Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 312-315
Aguilera, A.; Selgas, R.; Ruiz-Caravaca, M.L.; Bajo, M.A.; Cuesta, M.V.; Plaza, M.A.; Hernanz, A. 1999: Effects of recombinant human erythropoietin on functional and injury endothelial markers in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(Suppl 2): S161-S166
Chen, H.C.; Lai, Y.H.; Tsai, C.Y.; Shin, S.J.; Tsai, J.H. 1991: Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy Gaoxiong Yi Xue Ke Xue Za Zhi 7(2): 56-61